New industry rules require visual size checks or GP medical records for online fat jab purchases. The updated guidelines ensure weight-loss jabs like ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

A couple of months ago, healthcare equity research analyst Jared Holz from Mizuho spoke about Viking potentially being an ...

New checks on people wanting drugs such as Wegovy or Mounjaro will include verifying their body mass index in a video ...

NVO's fourth-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...

Shares of Novo Nordisk (NYSE: NVO) were moving higher on Wednesday. The company's stock gained 4.9% as of 1:50 p.m. ET, but gained as much as 5.8% earlier in the day. The leg up comes as the S&P 500 ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

More and more people are taking weight loss injectables like Wegovy — but not everyone prescribed these drugs should have ...

Truist Securities reaffirmed its Buy rating and $1,038.00 price target for Eli Lilly and Company (NYSE:LLY) shares, with analyst targets ranging from $580 to $1,190. The company, which has ...

More and more people are taking weight loss injectables like Wegovy and Mounjaro — and though ... As it stands today, in many places, anyone of age can buy GLP-1 drugs from online pharmacies ...

Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...

For one, semaglutide, the active ingredient in Wegovy, is being investigated in ... now is the best time to buy before it’s too late. And the numbers speak for themselves: Right now, we ...